Screener
X4 Pharmaceuticals XFOR Q4 2025 Annual earnings
Reported March 17, 2026 · Before market open
Revenue$2.6MBeat by $835.0K
EPS-$0.22Beat by $0.14
Revenue estimate$1.7M
EPS estimate-$0.36
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.3M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
FAQ
- When did X4 Pharmaceuticals report Q4 2025 earnings?
- X4 Pharmaceuticals (XFOR) reported Q4 2025 earnings on March 17, 2026 before market open.
- What were X4 Pharmaceuticals's Q4 2025 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $2.6M and eps of $-0.22 for Q4 2025.
- Did X4 Pharmaceuticals beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $1.7M by $835.0K. EPS beat the consensus estimate of $-0.36 by $0.14.
- How did X4 Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 79.1% from $1.4M a year earlier and eps grew 96.3% from $-6.01.
- Where can I find X4 Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001501697-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.
